NPI registry status
Active
2026 NPPES data Addiction Medicine (Psychiatry & Neurology) Physician NPI 1619119567 M.D.
Verify on CMS → Nicholas Fluitt, M.D.
Addiction Medicine (Psychiatry & Neurology) Physician in Mandeville, Louisiana.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 648 in Addiction Medicine (Psychiatry & Neurology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 103 beneficiaries · Addiction Medicine (Psychiatry & Neurology) Physician avg: 1K
Generic prescribing
93%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$104.13
2 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Nicholas Fluitt, M.D. filed 1,917 Medicare Part D claims in 2024 as an Addiction Medicine (Psychiatry & Neurology) Physician in Mandeville, Louisiana, prescribing 93% generic.
- 2K
- Part D claims, 2024
- 93%
- generic prescribing
- $104.13
- industry payments (Sunshine Act)
- ≥83rd
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Nicholas Fluitt, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1619119567), first enumerated 03/24/2009.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,917 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$104.13 in reported industry payments (2 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1619119567 · Addiction Medicine (Psychiatry & Neurology) Physician
NPI-10 · ENUM-MID · TAX-NARROW · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1619119567
- ENUM-MID 2009
- TAX-NARROW 648
- RX-MID 1,917
- BOOK-THIN 10 in Louisiana
- PHOTO-ENUM Jesse Markman, M.D. · 2009
Nicholas Fluitt, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
1,917 ≥ 83rd percentile 83% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Nicholas Fluitt, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Nicholas Fluitt, M.D.?
Quality data not reportedPrimary specialty
Addiction Medicine (Psychiatry & Neurology) Physician
Medicare Part D claims
1,917 85% vs specialty avg
Specialty distribution in Louisiana
How Addiction Medicine (Psychiatry & Neurology) Physician compares to other specialties among Louisiana providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Addiction Medicine (Psychiatry & Neurology) Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1619119567 |
|---|---|
| Specialty | Addiction Medicine (Psychiatry & Neurology) Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 03/24/2009 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Nicholas Fluitt, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$104
Largest payer
Axsome Therapeutics, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
Nicholas Fluitt, M.D. - brand share 7.0%
Addiction Medicine (Psychiatry & Neurology) Physician average
7% brand-name claims vs 93% generic, on 1,917 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,917
Total Claims
$171K
Total Drug Cost
103
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,542.5
- Total Day Supply
- 74,218
- Brand vs Generic
- 7% brand / 93% generic
- Brand Drug Cost
- $122K
- Generic Drug Cost
- $49K
Patient Demographics
- Average Patient Age
- 68.8 years
- Avg HCC Risk Score
- 1.13
- Gender Split
- 71% female / 29% male
- Age Distribution
- <65: 23, 65-74: 51, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Nicholas Fluitt, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Alprazolam
Alprazolam
201 claims
- Clonazepam
Clonazepam
105 claims
- Dextroamphetamine-…
Dextroamphetamine-Amphetamine
96 claims
- Fluoxetine Hcl
Fluoxetine Hcl
92 claims
- Lorazepam
Lorazepam
83 claims
- Trazodone Hcl
Trazodone Hcl
81 claims
- Sertraline Hcl 78
Sertraline Hcl
78 claims
- Quetiapine Fumarate 73
Quetiapine Fumarate
73 claims
| Drug | Claims |
|---|---|
| Alprazolam | 201 |
| Clonazepam | 105 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 96 |
| Fluoxetine Hcl | 92 |
| Lorazepam | 83 |
| Trazodone Hcl | 81 |
| Sertraline Hcl | 78 |
| Quetiapine Fumarate | 73 |
| Mirtazapine | 67 |
| Olanzapine | 53 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Addiction Medicine (Psychiatry & Neurology) Physician in LA →
All providers in Louisiana →
Compare specialties →
Addiction Medicine (Psychiatry & Neurology) Physician Overview
How Nicholas Fluitt, M.D. fits within the Addiction Medicine (Psychiatry & Neurology) Physician landscape nationally.
648
Addiction Medicine (Psychiatry & Neurology) Physician Providers in US
49
States with Addiction Medicine (Psychiatry & Neurology) Physician
1,039
Avg Claims per Provider
Nicholas Fluitt, M.D.'s 1,917 claims are above the specialty average of 1,039.
Nationwide Addiction Medicine (Psychiatry & Neurology) Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Fluitt, both outside Louisiana so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2009)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Addiction Medicine (Psychiatry & Neurology) Physician Providers in Louisiana
Other clinicians with the same primary specialty enrolled in Louisiana, drawn from the same CMS NPPES roster as Fluitt.
One of 10 Addiction Medicine (Psychiatry & Neurology) Physician providers enrolled in Louisiana, 5 are shown here.
Frequently Asked Questions
What is Nicholas Fluitt, M.D.'s specialty? ▼
Nicholas Fluitt, M.D. specializes in Addiction Medicine (Psychiatry & Neurology) Physician and practices in Mandeville, Louisiana. Credentials: M.D..
How much does Nicholas Fluitt, M.D. prescribe under Medicare Part D? ▼
In 2024, Nicholas Fluitt, M.D. wrote 1,917 Medicare Part D claims totaling $171K in drug costs for 103 beneficiaries.
Where is Nicholas Fluitt, M.D. located? ▼
Nicholas Fluitt, M.D. is located at 111 N CAUSEWAY BLVD STE 222, Mandeville, LA, 70448. Phone: (985) 231-2444.
What is Nicholas Fluitt, M.D.'s NPI number? ▼
Nicholas Fluitt, M.D.'s National Provider Identifier (NPI) is 1619119567, issued on 03/24/2009.
Does Nicholas Fluitt, M.D. prescribe more brand-name or generic drugs? ▼
Nicholas Fluitt, M.D.'s prescribing is 7% brand-name and 93% generic drugs by claim count, with $122K in brand drug costs.
How many Addiction Medicine (Psychiatry & Neurology) Physician providers are there in the US? ▼
There are 648 Addiction Medicine (Psychiatry & Neurology) Physician providers across 49 states in the US. The average Addiction Medicine (Psychiatry & Neurology) Physician provider writes 1,039 Medicare Part D claims per year.
What drugs does Nicholas Fluitt, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Nicholas Fluitt, M.D.'s most frequently prescribed drugs include Alprazolam, Clonazepam, Dextroamphetamine-Amphetamine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Nicholas Fluitt, M.D. accept Medicare? ▼
Nicholas Fluitt, M.D. appears in CMS Medicare data with 1,917 Part D claims and 103 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Nicholas Fluitt, M.D.'s credentials? ▼
Nicholas Fluitt, M.D.'s NPI is 1619119567 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.